Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Breast Cancer

  Free Subscription


Articles published in Radiology

Retrieve available abstracts of 56 articles:
HTML format



Single Articles


    December 2022
  1. GUPTA S, Mohindra N, Mehndiratta A, Chaturvedi P, et al
    Case 312.
    Radiology. 2022;305:743-745.
    PubMed     Abstract available


    November 2022
  2. CHUNG M, Calabrese E, Mongan J, Ray KM, et al
    Deep Learning to Simulate Contrast-enhanced Breast MRI of Invasive Breast Cancer.
    Radiology. 2022 Nov 15:213199. doi: 10.1148/radiol.213199.
    PubMed     Abstract available


    October 2022
  3. WOLFSON S, Kim E
    Breast Cancer Screening and Axillary Adenopathy in the Era of COVID-19 Vaccination.
    Radiology. 2022 Oct 11:222040. doi: 10.1148/radiol.222040.
    PubMed     Abstract available


  4. WEIGEL S, Heindel W, Hense HW, Decker T, et al
    Breast Density and Breast Cancer Screening with Digital Breast Tomosynthesis: A TOSYMA Trial Subanalysis.
    Radiology. 2022 Oct 4:221006. doi: 10.1148/radiol.221006.
    PubMed     Abstract available


  5. POTSCH N, Vatteroni G, Clauser P, Helbich TH, et al
    Contrast-enhanced Mammography versus Contrast-enhanced Breast MRI: A Systematic Review and Meta-Analysis.
    Radiology. 2022;305:94-103.
    PubMed     Abstract available


    September 2022
  6. KATAOKA M
    Mammographic Density for Personalized Breast Cancer Risk.
    Radiology. 2022 Sep 20:222129. doi: 10.1148/radiol.222129.
    PubMed    


  7. TRAN TXM, Kim S, Song H, Lee E, et al
    Association of Longitudinal Mammographic Breast Density Changes with Subsequent Breast Cancer Risk.
    Radiology. 2022 Sep 20:220291. doi: 10.1148/radiol.220291.
    PubMed     Abstract available


  8. RUEDA MA, Bedoya Murillo ND, Cardona Ortegon JD, Yepes MM, et al
    Abbreviated Screening MRI in Breast Cancer: Promising but Not Widely Available.
    Radiology. 2022 Sep 6:221727. doi: 10.1148/radiol.221727.
    PubMed    


    August 2022
  9. LEE SH, Jang MJ, Yoen H, Lee Y, et al
    Background Parenchymal Enhancement at Postoperative Surveillance Breast MRI: Association with Future Second Breast Cancer Risk.
    Radiology. 2022 Aug 30:220440. doi: 10.1148/radiol.220440.
    PubMed     Abstract available


  10. ABRAHAM P, Balthazar P, Reid NJ, Flores EJ, et al
    The Digital Divide in Radiology: Computer Use for Health Care-related Tasks and Breast Cancer Screening.
    Radiology. 2022 Aug 30:220796. doi: 10.1148/radiol.220796.
    PubMed    


  11. DEIPOLYI AR, Johnson CB, Riedl CC, Kunin H, et al
    Prospective Evaluation of Immune Activation Associated with Response to Radioembolization Assessed with PET/CT in Women with Breast Cancer Liver Metastasis.
    Radiology. 2022 Aug 16:220158. doi: 10.1148/radiol.220158.
    PubMed     Abstract available


  12. CHOI SJ, Lee SS, Jung KH, Lee JB, et al
    Noncirrhotic Portal Hypertension after Trastuzumab Emtansine in HER2-positive Breast Cancer as Determined by Deep Learning-measured Spleen Volume at CT.
    Radiology. 2022 Aug 9:220536. doi: 10.1148/radiol.220536.
    PubMed     Abstract available


  13. TAKAMATSU A, Yoshida K, Toshima F, Kozaka K, et al
    Single-Center Analysis of Pegfilgrastim-induced Aortitis Using a Drug Prescription Database and CT Findings.
    Radiology. 2022 Aug 9:220357. doi: 10.1148/radiol.220357.
    PubMed     Abstract available


    July 2022
  14. RAMTOHUL T, Tescher C, Vaflard P, Cyrta J, et al
    Prospective Evaluation of Ultrafast Breast MRI for Predicting Pathologic Response after Neoadjuvant Therapies.
    Radiology. 2022 Jul 26:220389. doi: 10.1148/radiol.220389.
    PubMed     Abstract available


  15. KIM G, Mehta TS, Brook A, Du LH, et al
    Enhancement Type at Contrast-enhanced Mammography and Association with Malignancy.
    Radiology. 2022 Jul 12:210966. doi: 10.1148/radiol.210966.
    PubMed     Abstract available


  16. LEE SA, Lee Y, Ryu HS, Jang MJ, et al
    Diffusion-weighted Breast MRI in Prediction of Upstaging in Women with Biopsy-proven Ductal Carcinoma in Situ.
    Radiology. 2022 Jul 5:213174. doi: 10.1148/radiol.213174.
    PubMed     Abstract available


    June 2022
  17. KIM SY, Cho N, Hong H, Lee Y, et al
    Abbreviated Screening MRI for Women with a History of Breast Cancer: Comparison with Full-Protocol Breast MRI.
    Radiology. 2022 Jun 14:213310. doi: 10.1148/radiol.213310.
    PubMed     Abstract available


    May 2022
  18. KIM S, Tran TXM, Song H, Ryu S, et al
    Mammographic Breast Density, Benign Breast Disease, and Subsequent Breast Cancer Risk in 3.9 Million Korean Women.
    Radiology. 2022 May 17:212727. doi: 10.1148/radiol.212727.
    PubMed     Abstract available


  19. KATAOKA M
    The Contribution of Imaging as a Prognostic Marker of Luminal Breast Cancer.
    Radiology. 2022 May 10:220748. doi: 10.1148/radiol.220748.
    PubMed    


  20. KWON BR, Shin SU, Kim SY, Choi Y, et al
    Microcalcifications and Peritumoral Edema Predict Survival Outcome in Luminal Breast Cancer Treated with Neoadjuvant Chemotherapy.
    Radiology. 2022 May 10:211509. doi: 10.1148/radiol.211509.
    PubMed     Abstract available


  21. WANDERS AJT, Mees W, Bun PAM, Janssen N, et al
    Interval Cancer Detection Using a Neural Network and Breast Density in Women with Negative Screening Mammograms.
    Radiology. 2022;303:269-275.
    PubMed     Abstract available


    April 2022
  22. TAOUREL P
    MRI to Detect Contralateral Breast Cancer in Patients with Newly Diagnosed Breast Cancer: An Increase in Overall Survival to Be Confirmed.
    Radiology. 2022 Apr 26:220546. doi: 10.1148/radiol.220546.
    PubMed    


  23. FREITAS V, Li X, Amitai Y, Au F, et al
    Contralateral Breast Screening with Preoperative MRI: Long-Term Outcomes for Newly Diagnosed Breast Cancer.
    Radiology. 2022 Apr 26:212361. doi: 10.1148/radiol.212361.
    PubMed     Abstract available


  24. LAURITZEN AD, Rodriguez-Ruiz A, von Euler-Chelpin MC, Lynge E, et al
    An Artificial Intelligence-based Mammography Screening Protocol for Breast Cancer: Outcome and Radiologist Workload.
    Radiology. 2022 Apr 19:210948. doi: 10.1148/radiol.210948.
    PubMed     Abstract available


    March 2022
  25. LARSEN M, Aglen CF, Lee CI, Hoff SR, et al
    Artificial Intelligence Evaluation of 122 969 Mammography Examinations from a Population-based Screening Program.
    Radiology. 2022 Mar 29:212381. doi: 10.1148/radiol.212381.
    PubMed     Abstract available


    February 2022
  26. LEE AY, Ray KM
    Surrogate Clinical End Points for Breast Cancer Screening Using Digital Breast Tomosynthesis.
    Radiology. 2022 Feb 1:213026. doi: 10.1148/radiol.213026.
    PubMed    


  27. PATTACINI P, Nitrosi A, Giorgi Rossi P, Duffy SW, et al
    A Randomized Trial Comparing Breast Cancer Incidence and Interval Cancers after Tomosynthesis Plus Mammography versus Mammography Alone.
    Radiology. 2022 Feb 1:211132. doi: 10.1148/radiol.211132.
    PubMed     Abstract available


  28. GRIMM LJ, Rahbar H, Abdelmalak M, Hall AH, et al
    Ductal Carcinoma in Situ: State-of-the-Art Review.
    Radiology. 2022;302:246-255.
    PubMed     Abstract available


  29. KOPANS DB
    Time for Change in Digital Breast Tomosynthesis Research.
    Radiology. 2022;302:293-294.
    PubMed    


    January 2022
  30. SHOSHAN Y, Bakalo R, Gilboa-Solomon F, Ratner V, et al
    Artificial Intelligence for Reducing Workload in Breast Cancer Screening with Digital Breast Tomosynthesis.
    Radiology. 2022 Jan 18:211105. doi: 10.1148/radiol.211105.
    PubMed     Abstract available


  31. PHILPOTTS LE
    Advancing Artificial Intelligence to Meet Breast Imaging Needs.
    Radiology. 2022 Jan 18:213101. doi: 10.1148/radiol.213101.
    PubMed    


  32. BERNSTEIN MH, Baird GL, Lourenco AP
    Digital Breast Tomosynthesis and Digital Mammography Recall and False-Positive Rates by Time of Day and Reader Experience.
    Radiology. 2022 Jan 11:210318. doi: 10.1148/radiol.210318.
    PubMed     Abstract available


  33. HOU R, Grimm LJ, Mazurowski MA, Marks JR, et al
    Prediction of Upstaging in Ductal Carcinoma in Situ Based on Mammographic Radiomic Features.
    Radiology. 2022 Jan 4:210407. doi: 10.1148/radiol.210407.
    PubMed     Abstract available


    December 2021
  34. FUCHSJAGER MH, Adelsmayr G
    Artificial Intelligence as an Assistant in Breast Cancer Screening.
    Radiology. 2021 Dec 14:212675. doi: 10.1148/radiol.212675.
    PubMed    


  35. COZZI A, Magni V, Zanardo M, Schiaffino S, et al
    Contrast-enhanced Mammography: A Systematic Review and Meta-Analysis of Diagnostic Performance.
    Radiology. 2021 Dec 14:211412. doi: 10.1148/radiol.211412.
    PubMed     Abstract available


  36. ROMERO-MARTIN S, Elias-Cabot E, Raya-Povedano JL, Gubern-Merida A, et al
    Stand-Alone Use of Artificial Intelligence for Digital Mammography and Digital Breast Tomosynthesis Screening: A Retrospective Evaluation.
    Radiology. 2021 Dec 14:211590. doi: 10.1148/radiol.211590.
    PubMed     Abstract available


  37. LIANG A, Baraban E, Myers KS, Mullen LA, et al
    Developing Asymmetries without Sonographic Correlate at Digital Breast Tomosynthesis.
    Radiology. 2021 Dec 7:210527. doi: 10.1148/radiol.210527.
    PubMed     Abstract available


  38. GASTOUNIOTI A, Pantalone L, Scott CG, Cohen EA, et al
    Fully Automated Volumetric Breast Density Estimation from Digital Breast Tomosynthesis.
    Radiology. 2021;301:561-568.
    PubMed     Abstract available


  39. ZHU X, Wolfgruber TK, Leong L, Jensen M, et al
    Deep Learning Predicts Interval and Screening-detected Cancer from Screening Mammograms: A Case-Case-Control Study in 6369 Women.
    Radiology. 2021;301:550-558.
    PubMed     Abstract available


    November 2021
  40. FAN M, Cui Y, You C, Liu L, et al
    Radiogenomic Signatures of Oncotype DX Recurrence Score Enable Prediction of Survival in Estrogen Receptor-Positive Breast Cancer: A Multicohort Study.
    Radiology. 2021 Nov 30:210738. doi: 10.1148/radiol.2021210738.
    PubMed     Abstract available


  41. TICE JA, Gard CC, Miglioretti DL, Sprague BL, et al
    Comparing Mammographic Density Assessed by Digital Breast Tomosynthesis or Digital Mammography: The Breast Cancer Surveillance Consortium.
    Radiology. 2021 Nov 23:204579. doi: 10.1148/radiol.2021204579.
    PubMed     Abstract available


  42. MORI N, Mugikura S, Takase K
    Extra- or Peritumoral Hyperintensity on T2-weighted Images in Patients with Breast Cancer.
    Radiology. 2021 Nov 16:210939. doi: 10.1148/radiol.2021210939.
    PubMed    


  43. GEERTSE TD, Setz-Pels W, van der Waal D, Nederend J, et al
    Added Value of Prereading Screening Mammograms for Breast Cancer by Radiologic Technologists on Early Screening Outcomes.
    Radiology. 2021 Nov 9:210746. doi: 10.1148/radiol.2021210746.
    PubMed     Abstract available


  44. PISANO ED
    How Radiologists Can Improve Breast Cancer Screening.
    Radiology. 2021 Nov 9:211525. doi: 10.1148/radiol.2021211525.
    PubMed    


    October 2021
  45. HELLER SL
    Impact of the Pandemic on Breast Cancer Diagnoses.
    Radiology. 2021 Oct 19:212477. doi: 10.1148/radiol.2021212477.
    PubMed    


  46. HICKMAN SE, Woitek R, Le EPV, Im YR, et al
    Machine Learning for Workflow Applications in Screening Mammography: Systematic Review and Meta-Analysis.
    Radiology. 2021 Oct 19:210391. doi: 10.1148/radiol.2021210391.
    PubMed     Abstract available


  47. LOWRY KP, Bissell M, Miglioretti DL, Kerlikowske K, et al
    Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic.
    Radiology. 2021 Oct 19:211808. doi: 10.1148/radiol.2021211808.
    PubMed     Abstract available


  48. MANKOFF DA, Sellmyer MA
    PET of Fibroblast-Activation Protein for Breast Cancer Diagnosis and Staging.
    Radiology. 2021 Oct 12:212098. doi: 10.1148/radiol.2021212098.
    PubMed    


  49. BACKHAUS P, Burg MC, Roll W, Buther F, et al
    Simultaneous FAPI PET/MRI Targeting the Fibroblast-Activation Protein for Breast Cancer.
    Radiology. 2021 Oct 12:204677. doi: 10.1148/radiol.2021204677.
    PubMed     Abstract available


  50. VERBURG E, van Gils CH, van der Velden BHM, Bakker MF, et al
    Deep Learning for Automated Triaging of 4581 Breast MRI Examinations from the DENSE Trial.
    Radiology. 2021 Oct 5:203960. doi: 10.1148/radiol.2021203960.
    PubMed     Abstract available


    August 2021
  51. ONISHI N, Li W, Newitt DC, Harnish RJ, et al
    Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response.
    Radiology. 2021 Aug 24:203645. doi: 10.1148/radiol.2021203645.
    PubMed     Abstract available


  52. IMBRIACO M
    Reducing False-Positive Screening MRI Rates in Women with Extremely Dense Breasts.
    Radiology. 2021 Aug 17:211547. doi: 10.1148/radiol.2021211547.
    PubMed    


  53. DEN DEKKER BM, Bakker MF, de Lange SV, Veldhuis WB, et al
    Reducing False-Positive Screening MRI Rate in Women with Extremely Dense Breasts Using Prediction Models Based on Data from the DENSE Trial.
    Radiology. 2021 Aug 17:210325. doi: 10.1148/radiol.2021210325.
    PubMed     Abstract available


  54. CHOU SS, Romanoff J, Lehman CD, Khan SA, et al
    Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
    Radiology. 2021 Aug 3:204743. doi: 10.1148/radiol.2021204743.
    PubMed     Abstract available


    July 2021
  55. BAE SJ, Cha YJ, Eun NL, Ji JH, et al
    Diagnostic Accuracy of Nonmass Enhancement at Breast MRI in Predicting Tumor Involvement of the Nipple: A Prospective Study in a Single Institution.
    Radiology. 2021 Jul 13:204136. doi: 10.1148/radiol.2021204136.
    PubMed     Abstract available


    June 2021
  56. LEE CS, Moy L, Hughes D, Golden D, et al
    Radiologist Characteristics Associated with Interpretive Performance of Screening Mammography: A National Mammography Database (NMD) Study.
    Radiology. 2021 Jun 22:204379. doi: 10.1148/radiol.2021204379.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: